Wagner HN. Clinical PET: its time has come. J Nucl Med. 1991;32(4):561–4.

PubMed  Google Scholar 

Ter-Pogossian MM, Phelps ME, Hoffman EJ, Mullani NA. A positron-emission transaxial tomograph for nuclear imaging (PETT). Radiology. 1975;114(1):89–98.

CAS  Article  Google Scholar 

Muehllehner G, Karp JS. Positron emission tomography. Phys Med Biol. 2006;51(13):R117–37.

CAS  Article  Google Scholar 

Melcher CL. Scintillation crystals for PET. J Nucl Med. 2000;41(6):1051–5.

CAS  PubMed  Google Scholar 

Mullani NA, Markham J, Ter-Pogossian MM. Feasibility of time-of-flight reconstruction in positron emission tomography. J Nucl Med. 1980;21(11):1095–7.

CAS  PubMed  Google Scholar 

Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, et al. Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients. Eur J Nucl Med Mol Imaging. 2015;42(13):2072–82.

Article  PubMed Central  Google Scholar 

Dahlbom M, Hoffman EJ, Hoh CK, Schiepers C, Rosenqvist G, Hawkins RA, et al. Whole-body positron emission tomography: part I. methods and performance characteristics. J Nucl Med. 1992;33(6):1191–9.

CAS  PubMed  Google Scholar 

López-Mora DA, Carrió I, Flotats A. Digital PET vs analog PET: clinical implications? Semin Nucl Med. 2022;52(3):302–11.

Article  Google Scholar 

Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169.

Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med. 2018;59(1):3–12.

CAS  Article  PubMed Central  Google Scholar 

Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the EXPLORER Total-body PET scanner. J Nucl Med. 2019;60(3):299–303.

CAS  Article  PubMed Central  Google Scholar 

Zhang X, Xie Z, Berg E, Judenhofer MS, Liu W, Xu T, et al. Total-body dynamic reconstruction and parametric imaging on the uEXPLORER. J Nucl Med. 2020;61(2):285–91.

CAS  Article  PubMed Central  Google Scholar 

Spencer BA, Berg E, Schmall JP, Omidvari N, Leung EK, Abdelhafez YG, et al. Performance evaluation of the uEXPLORER Total-body PET/CT scanner based on NEMA NU 2-2018 with additional tests to characterize PET scanners with a long axial field of view. J Nucl Med. 2021;62(6):861–70.

Article  PubMed Central  Google Scholar 

Sari H, Mingels C, Alberts I, Hu J, Buesser D, Shah V, et al. First results on kinetic modelling and parametric imaging of dynamic 18F-FDG datasets from a long axial FOV PET scanner in oncological patients. Eur J Nucl Med Mol Imaging. 2022;49(6):1997–2009.

CAS  Article  Google Scholar 

Alberts I, Hünermund JN, Prenosil G, Mingels C, Bohn KP, Viscione M, et al. Clinical performance of long axial field of view PET/CT: a head-to-head intra-individual comparison of the biograph vision Quadra with the biograph vision PET/CT. Eur J Nucl Med Mol Imaging. 2021;48(8):2395–404.

CAS  Article  PubMed Central  Google Scholar 

Karp JS, Viswanath V, Geagan MJ, Muehllehner G, Pantel AR, Parma MJ, et al. PennPET Explorer: design and preliminary performance of a whole-body imager. J Nucl Med. 2020;61(1):136–43.

CAS  Article  PubMed Central  Google Scholar 

Pantel AR, Viswanath V, Daube-Witherspoon ME, Dubroff JG, Muehllehner G, Parma MJ, et al. PennPET Explorer: human imaging on a whole-body imager. J Nucl Med. 2020;61(1):144–51.

CAS  Article  PubMed Central  Google Scholar 

Hofman MS, Lawrentschuk N, Francis RJ, Tang C, Vela I, Thomas P, et al. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study. Lancet. 2020;395(10231):1208–16.

CAS  Article  Google Scholar 

Berg E, Gill H, Marik J, Ogasawara A, Williams S, van Dongen G, et al. Total-body PET and highly stable chelators together enable meaningful 89Zr-antibody-PET studies up to 30 days post-injection. J Nucl Med. 2020;61(3):453–60.

CAS  Article  PubMed Central  Google Scholar 

Dow E, Freimund A, Smith K, Hicks RJ, Jurcevic P, Shackleton M, et al. Cancer diagnoses following abnormal noninvasive prenatal testing: a case series, literature review, and proposed management model. JCO Precis Oncol. 2021;5:1001–12.

Article  Google Scholar 

Amar L, Pacak K, Steichen O, Akker SA, Aylwin SJB, Baudin E, et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol. 2021;17(7):435–44.

CAS  Article  PubMed Central  Google Scholar